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Abstract
Background: Whilst previous work has identified clustering of the active trachoma sign “trachomatous
inflammation—follicular” (TF), there is limited understanding of the spatial structure of trachomatous trichiasis (TT),
the rarer, end-stage, blinding form of disease. Here we use community-level TF prevalence, information on access
to water and sanitation, and large-scale environmental and socio-economic indicators to model the spatial variation
in community-level TT prevalence in Benin, Cote d’Ivoire, DRC, Guinea, Ethiopia, Malawi, Mozambique, Nigeria,
Sudan and Uganda.
Methods: We fit binomial mixed models, with community-level random effects, separately for each country. In
countries where spatial correlation was detected through a semi-variogram diagnostic check we then fitted a
geostatistical model to the TT prevalence data including TF prevalence as an explanatory variable.
Results: The estimated regression relationship between community-level TF and TT was significant in eight
countries. We estimate that a 10% increase in community-level TF prevalence leads to an increase in the odds for
TT ranging from 20 to 86% when accounting for additional covariates.
Conclusion: We find evidence of an association between TF and TT in some parts of Africa. However, our results
also suggest the presence of additional, country-specific, spatial risk factors which modulate the variation in TT risk.
Keywords: Trachoma, Trichiasis, Blindness, Visual impairment, Neglected tropical disease, Epidemiology, Global
trachoma mapping project
Background
Trachoma is a blinding disease caused by recurrent ocu-
lar Chlamydia trachomatis infection, an organism that
produces chronic inflammation of the tarsal conjunctiva.
This is characterised by sub-epithelial follicles, which
may meet the definition for the sign trachomatous in-
flammation—follicular (TF) [1]. TF is the sign whose
prevalence in 1–9-year-olds is used to determine
whether public health-level interventions against active
(inflammatory) trachoma are needed [2]. Through re-
peated reinfection [3, 4], conjunctival scarring may de-
velop, eventually causing the eyelashes to turn inward and
touch the globe, a state known as trachomatous trichiasis
(TT). In-turned eyelashes that abrade the cornea can re-
sult in corneal opacity and blindness [1]. Corrective sur-
gery [5, 6] or epilation [7] are used to manage TT.
Ocular chlamydial transmission is declining in many
countries [8–11] suggesting exceptional progress in
interrupting the transmission cycle. Until recently TT
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prevalence was only evaluated within the context of TF
surveys [12]. As TT plays an essential role in trachoma
elimination, it remains important to focus on areas
where TT is still a public health problem, even in the ab-
sence of TF.
The pathogenesis of trachoma, implicitly conceptual-
ized within WHO recommendations for district-level in-
terventions, is of repeated episodes of active trachoma
incrementally increasing the cumulative risk of TT. It
should be noted that this may be a simplistic outlook on
the complicated pathway to TT and additional elements
may influence progression. However, active trachoma is
a pre-requisite on TT’s causal pathway, with moderate
to high prevalences of TF being a proxy for current
transmission of ocular C. trachomatis, and TT a proxy
for historic transmission. The prevalence levels of these
signs are therefore signals for C. trachomatis transmis-
sion intensity at different times (TF is current, and TT is
historic and cumulative). Even though TF prevalence
and TT prevalence are markers of transmission at differ-
ent time points or over different time scales, in areas
where antibiotic mass drug administration (MDA) for
trachoma [13] has not yet occurred, it is often assumed
that ocular C. trachomatis transmission intensity has
remained more or less constant over decades, and that
TF prevalence and TT prevalence will therefore closely
correlate. This assumption is reasonable if access to
water, sanitation, hygiene and anti-chlamydial antibiotics
at community level have been constant or have changed
only gradually. However, such an assumption is not al-
ways valid [14, 15].
Many national programmes [8] have successfully re-
duced TF prevalence in children aged 1–9 years below
the elimination threshold of 5% [16] in some or many
districts. To eliminate trachoma as a public health prob-
lem, district-level TT prevalence must also be reduced
below 0.2% in adults aged ≥15 years [16]. Whether or
not active trachoma and TT are public health problems
are two separate questions. In Nigeria, for example, 94
local government areas in six states mapped through the
Global Trachoma Mapping Project (GTMP) yielded
district-level TF prevalence estimates below the elimin-
ation threshold and district-level TT prevalence esti-
mates above the threshold [17–23]. This is attributable
to historic transmission intensity being considerably
higher than the contemporary one. It is important to
better understand the factors associated with high TT
burden, so as to develop more targeted control interven-
tions. Understanding where TT cases are likely to occur
could help to guide strategic placement of TT interven-
tion services.
Thanks to the GTMP, there has been an increasing
availability of high quality geolocated trachoma and
water, sanitation and hygiene (WASH) data. The GTMP
was launched in December 2012 with the aim of map-
ping the global prevalence of trachoma in all
suspected-endemic districts, through completion of
population based prevalence surveys. It systematically
collected trachoma and WASH data across 1546 districts
in 29 countries, nearly exclusively in areas where control
activities, including antibiotic MDA, had not yet oc-
curred [24]. These data can be used to further our un-
derstanding of TT distribution.
In this study, we attempted to identify risk factors that,
in addition to TF, might associate with variation in
community-level TT prevalence. To this end we fit bino-
mial mixed models, with random effects at community
level, to GTMP baseline data from ten countries. We
then test for residual spatial correlation and, in countries
where this is detected, use geostatistical methods in
order to model the variation in TT prevalence between
countries.
Methods
Data
Ten GTMP collaborating countries provided data for
this study: Benin, Cote d’ Ivoire, Democratic Republic of
the Congo (DRC), Ethiopia, Guinea, Malawi,
Mozambique, Nigeria, Sudan and Uganda. Data provided
were from 15,051 clusters (or communities) within 624
trachoma elimination intervention-naïve evaluation units
(EUs) (Table 1). Individual-level information on the
presence or absence of TF and TT, as well as water and
sanitation access of geolocated households, were
provided.
Community-level TT prevalence was calculated as the
ratio between the number of adults aged ≥15 years with
trichiasis in at least one eye and the number of adults
aged ≥15 years examined. Community-level TF preva-
lence was calculated as the ratio between the number of
children aged 1–9 years with TF in at least one eye and
the number of children aged 1–9 years examined.
Physical and social environmental factors are hypothe-
sized to play an important role in the natural history of
trachoma. These factors could conceivably alter rate of
progression to TT (Fig. 1).
Facial cleanliness is a well-established association of
TF [25–30]. Access to water is necessary to facilitate
personal hygiene practices. Previous studies have found
an association between distance to water and risk of
trachoma [25, 31–33]. There is mixed evidence on
higher density populations of Musca sorbens, the fly vec-
tor for ocular C. trachomatis, being associated with a
greater risk of trachoma [27, 34]. M. sorbens prefers to
breed on human faeces left exposed on the soil [35, 36]
and so it may be that latrine ownership has a protective
association against active trachoma [37]. For this ana-
lysis, community-level WASH indicators were created
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from the GTMP household-level WASH dataset (Ap-
pendix 1). The categorization of these indicators was in-
formed by the WHO/UNICEF Joint Monitoring
Programme for Water Supply and Sanitation (JMP) [38].
We calculated the prevalence of access to each catego-
rized WASH indicator.
Previous studies have shown that lower precipitation
levels and higher temperatures can lead to an increase in
the risk of TF [39]. Therefore, we selected climate-related
factors, including annual total precipitation, mean
temperature, aridity index and potential evapo-transpiration
for this analysis. Gridded maps at 1 km2 resolution of annual
total precipitation and mean temperature were extracted
from the WorldClim database [40]. The aridity index and
potential evapo-transpiration (PET) raster datasets of 1 km2
resolution, were obtained from the Consortium for Spatial
Information (CGIAR-CSI) [41]. CGIAR-CSI modelled arid-
ity index and PET using the data available from WorldClim
as input parameters.
It has been suggested that frequent sandstorms that
occur in some areas of Sudan cause eye trauma [42]. Irri-
tation of the eyes leads to rubbing with fingers which
could potentially accelerate the progression of TT. Hence,
in our analysis we consider the proportion of sand in
Table 1 Summary of GTMP data included in the analysis
Country No. of
communities
TF in children aged 1–9 years TT in adults aged ≥15 years
No. examined No. positive (%) No. communities
prevalence ≥5%
No. examined No. positive (%) No. communities with
prevalence ≥0.2%
Benin 213 18,781 1594 (8.5%) 94 (44.1%) 16,170 254 (1.6%) 89 (41.8%)
Cote d’Ivoire 256 17,658 1829 (10.4%) 174 (68%) 18,771 39 (0.2%) 26 (10.2%)
DRC 1023 74,142 7022 (9.5%) 610 (59.6%) 52,200 1137 (2.2%) 511 (50%)
Ethiopia 4480 186,308 40,131 (21.5%) 3119 (69.6%) 289,230 4711 (1.6%) 2154 (48.1%)
Guinea 295 19,488 832 (4.3%) 98 (33.2%) 21,955 66 (0.3%) 53 (18%)
Malawi 1948 82,185 3437 (4.2%) 561 (28.8%) 110,815 358 (0.3%) 259 (13.3%)
Mozambique 696 34,602 2133 (6.2%) 297 (42.7%) 35,895 155 (0.4%) 117 (16.8%)
Nigeria 5364 337,962 10,070 (3%) 1105 (20.6%) 371,928 4815 (1.3%) 2035 (37.9%)
Sudan 667 33,830 1394 (4.1%) 172 (25.8%) 40,501 327 (0.8%) 197 (29.5%)
Uganda 109 6019 183 (3%) 26 (23.9%) 7445 21 (0.3%) 20 (18.3%)
Total 15,051 810,975 68,625 (8.5%) 6256 (41.6%) 964,910 11,883 (1.2%) 5461 (36.3%)
Fig. 1 Conceptual framework of environmental risk factors influencing progression to TT
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topsoil as a potential risk factor for TT. These data were
obtained from the ISRIC-World Soil Information project
included in the Harmonized Soil Map of the World [43].
We speculate that access to healthcare and other
services are associated with developed infrastructure,
and therefore sought an infrastructure indicator. Light
density at night has been shown to be correlated with
local economic activity and gross production rate at
different scales [44, 45]. Night light emission captured
by the Operational Linescan System instrument on
board a satellite of the Defence Meteorological Satel-
lite Program was used as a proxy measure of poverty
across Africa [46, 47]. A gridded map of straight line
distances to stable lights, namely night light emissivity
> 0, was subsequently produced from the raw night
light raster for 1997. This historic year was chosen
because we were interested in a measure of infra-
structure during the childhood of survey participants,
rather than that at the time of the surveys themselves
and the mean age of participants is 36 years.
All the aforementioned environmental datasets were de-
rived from georeferenced raster files, and converted to a
standardized resolution of 5 km× 5 km. The georeferenced
data were linked in ArcGIS 10.1 (ESRI, Redlands, CA,
USA). When shrinkage of spatial resolution was needed for
the 1 km2 resolution covariates, we estimated the mean
value in a 5 km× 5 km window using the aggregate tool in
the Spatial Analyst toolbox of ArcGIS 10.1 (Appendix 2).
To identify collinearity among the selected variables, we
used the variance inflation factor (VIF) [48], defined as
VIF j ¼ 1
1−R2j
where Rj
2 is the fraction of explained variance in the j-th
explanatory variables by the other explanatory variables.
Model formulation
Let pi denote the probability of having TT, β0 is the
intercept and Ui is community-level unstructured ran-
dom effects (let i denote the i-th community). We fit the
following nested binomial mixed models, where γTFi is
the regression coefficient for the effect of TF prevalence
on the log-odds of TT:
M1 : log
pi
1−pi
 
¼ β0 þ Ui;
M2 : logð pi
1−pi
Þ ¼ β0 þ γT Fi þ Ui;
M3 : logð pi
1−pi
Þ ¼ β0 þ γT Fi þ
X
j¼1
β jdi j þ Ui;
where dij in M3 are the explanatory variables described
in the previous section. We use the log-likelihood ratio
test to select among the three models defined above.
In fitting M3, we also carried out variable selection
using a backward stepwise approach, starting from the
mixed effects model with all the variables included. The
likelihood-ratio test was used to test for the significance
of each variable, with terms removed one by one until
all those remaining were significant at 5% level.
To assess the presence of residual spatial correl-
ation, we first obtained a point estimate of the
community-level unstructured random effects Ui from
the best model identified in the previous step, and
then computed the empirical semi-variogram. A semi-
variogram provides insights into the rate of decay of
spatial autocorrelation in the data. It does this by
computing the mean squared difference between pairs
of residuals as a function of the distance between
their associated geographical locations. A flat
semi-variogram is interpreted as evidence against the
presence of spatial correlation. To test for spatial cor-
relation more formally, we also generated 95% confi-
dence intervals under the assumption of spatial
independence. These intervals were obtained by com-
puting semi-variograms on 1000 randomly permuted
point estimates of Ui, while holding the geographical
locations fixed.
In cases where we found evidence of spatial correl-
ation, we fitted geostatistical binomial logistic models, in
which Ui was modelled as a spatial Gaussian process
with a stationary and isotropic correlation function. All
the geostatistical models were fitted in the PrevMap [49]
package.
Results
The output for the cluster-level tests suggested that
temperature, precipitation, aridity index, and PET inter-
act with one another (Table 2). Since aridity was highly
correlated with each of these indicators, we retained this
variable and excluded the remainder.
The strength of association for variables in the full
mixed effects model varied between countries (Table 3).
Table 2 Multicollinearity test results for gridded covariates
Variable VIF
Annual mean temperature 5.4
Annual total precipitation 47.6
Aridity Index 62.3
Potential evapo-transpiration 6.4
Euclidean distance to ground water 1.2
Sand/soil fraction 2.0
Stable Night Light (1997) 1.2
Accessibility 1.3
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There was very strong evidence of association (P < 0.05)
between community-level TF prevalence and TT preva-
lence in all countries except Guinea and Uganda. In con-
trast, there was evidence of association with access to
latrines in 4 of 10 countries (DRC, Ethiopia,
Mozambique and Nigeria (p < 0.01)), with access to im-
proved latrines in 2 countries (Nigeria and Uganda (p <
0.05)), and with water source variables in 3 countries
(Ethiopia, Nigeria and Guinea (p < 0.05)). Observed rela-
tionships with environmental factors were equally het-
erogeneous, with associations observed with aridity
index in DRC, Ethiopia, Nigeria and Sudan; and with
sand/soil fraction only in Benin and Ethiopia. Night light
was associated in DRC, Ethiopia, Mozambique and
Nigeria.
The nested mixed effects models (Table 4) show
that when TF was added as a fixed effect, the
proportional reduction in variance ranged from 0.06
(Nigeria) to 0.42 (Benin). When environmental risk
factors were added, the proportional change in vari-
ance ranged from 0.25 (Ethiopia) to 0.79 (Cote
d’Ivoire). In all countries, variance continued to de-
crease as TF and then environmental risk factors were
added to the model.
The best models, selected using the likelihood ratio
test, are shown in Table 5. DRC, Ethiopia and Nigeria
maintained the largest number of variables significant at
the 5% level. These three countries also had the largest
quantities of data available.
Semi-variograms generated with Pearson’s residuals of
the best fitting non-spatial binomial models suggest
presence of residual spatial correlation in Benin, DRC,
Ethiopia, Mozambique and Sudan. The 95% confidence
Table 4 Comparison of variance explained by each mixed effects model
Null model TF only model TF prevalence +
risk factors model
Benin Variance 2.25 1.3 1.09
Proportional reduction Null model 0.42 0.52
TF only model 0.16
Cote d’Ivoire Variance 13.75 10.28 2.92
Proportional reduction Null model 0.79
TF only model
DRC Variance 1.52 1.23 1.05
Proportional reduction Null model 0.19 0.31
TF only model 0.15
Ethiopia Variance 1.22 1.01 0.92
Proportional reduction Null model 0.17 0.25
TF only model 0.09
Guinea Variance 1.88 1.87* 1.37
Proportional reduction Null model 0.27
TF only model
Malawi Variance 2.17 1.96 1.59
Proportional reduction Null model 0.1 0.27
TF only model 0.19
Mozambique Variance 4.45 3.52 3.06
Proportional reduction Null model 0.21 0.31
TF only model 0.13
Nigeria Variance 1.93 1.82 0.99
Proportional reduction Null model 0.06 0.49
TF only model 0.46
Sudan Variance 1.98 1.85 1.15
Proportional reduction Null model 0.07 0.42
TF only model 0.38
Flueckiger et al. BMC Infectious Diseases          (2019) 19:364 Page 6 of 16
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intervals generated under the assumption of spatial inde-
pendence demonstrate spatial correlation in these coun-
tries (Fig. 2).
The distance at which spatial correlation fell below
5% ranged from 3.0 km (in Ethiopia) (95% credible
interval 1.6–6.0 km) to 14.2 km (in Mozambique)
(95% credible interval 3.3–76.4 km), corresponding
with a very rapid decline in spatial correlation with
distance at larger scales, after accounting for covari-
ates (Table 6).
Fig. 2 Semi-variograms were generated with Pearson’s residuals derived from the best fitting non-spatial mixed methods model. The 95%
confidence intervals (red dashed lines) and semi-variogram (black dashed line) created through generating 1000 simulations are displayed here.
All distances are in kilometres
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Discussion
We investigated factors associated with community-level
TT prevalence after considering the community-level TF
prevalence and spatial dependency, to try and understand
what causes this variation. We demonstrated considerable
variation in the relationship between community-level TF
and TT. When accounting for other covariates, the mixed
effects models demonstrated a strong association between
community-level TF and TT in eight of ten countries.
These models estimate that a 10% increase in
community-level TF prevalence is associated with an in-
crease in the odds for TT of 20 to 86%, varying with setting.
Benin, Cote d’Ivoire and Mozambique had exceptionally
high increments in odds ratios with increasing TF, whereby
a 10% increase in community-level TF prevalence was asso-
ciated with an increase in TT odds of 78, 86 and 74% re-
spectively. These high increments in odds ratios for TT
lead us to speculate that reductions in TF prevalence in
these environments will be quickly followed by a reduction
in the incidence of TT. The relatively low increments in
odds ratios in Ethiopia and Nigeria, where a 10% increase
in community-level TF prevalence associated with an in-
crease in TT odds of only 23 and 20% respectively, suggest
a slight disconnect between historic and current transmis-
sion. This could be a signal of (1) a change in transmission
dynamics over time, (2) population movement, (3) a pointer
to the fact that we are using all-trichiasis as the dependent
variable, rather than only trichiasis due to trachoma or (4)
other factors are influencing TT aside from C. trachomatis.
Further analysis is needed to explore the influence on the
relationships that we observed here of including data on
the presence or absence of trachomatous conjunctival scar-
ring in eyes with trichiasis.
Importantly, in these models, the proportion of variance
explained by TF ranges from 6% (in Nigeria) to 42% (in
Benin). This range highlights the complex relationship of
the distribution of TT and the distribution of TF. Environ-
mental covariates, on average, explain an additional 9% (in
Ethiopia) to 46% (in Nigeria) of variance. Our models sug-
gest that while community-level TF prevalence is gener-
ally the strongest single predictor of TT, it does not fully
explain the variation in community-level TT prevalence,
and implying that occasionally, high-TT-prevalence popu-
lations will be found where TF is rare. It has been widely
observed that dry conditions (parameterized in our ana-
lysis as a low aridity index) is a risk factor for TF in chil-
dren [31, 50–52]. We found an extension of this
association in three of our countries, in the form of an as-
sociation of low aridity index with increased TT preva-
lence. However, in Sudan we observed the phenomenon
of an unexpectedly-positive association between
community-level TT prevalence and aridity index. This
counter-intuitive relationship may be attributed to coin-
fections facilitated in humid climates. It has been shown
that coinfection with other bacteria [53], such as Strepto-
coccus pneumoniae and Staphylococcus aureus [54], could
influence progression of TT [55].
High levels of self-reported latrine use by adults, aridity
index and 1997 night light had strongly significant associa-
tions with TT prevalence in only three of ten countries.
This suggests that hygiene practices, dry climate and his-
toric infrastructure may link to increased community-level
TT prevalence in some settings, but generally they do not.
Previous studies have clearly shown the association be-
tween access to WASH and risk of TF [25, 32, 39, 56] and
so it is not surprising that our models, which account for
TF prevalence, generally do not demonstrate significant re-
sidual associations between TT and WASH variables. The
variation in direction of association may be an artefact of
WASH improvements over time, or—hypothetically—exist-
ence of latrines themselves could contribute to facilitating
M. sorbens breeding if the latrines are not appropriately
maintained, thereby deterring some potential users whilst
protecting householders from legal or peer pressure to
build an adequate facility. The development of TT requires
many previous C. trachomatis infections [4] and so popula-
tions that historically had poor WASH access may now
have high TT burdens, even if the WASH situation has
since improved.
Many other studies have identified correlates of high TF
prevalence, including potential socio-economic, demo-
graphic and environmental risk factors [25, 32, 39, 56–58],
and have explored TF’s spatial distribution at different geo-
graphic scales [33, 52, 59–61]. However, few studies have
specifically examined TT’s environmental risk factors and
spatial distribution [42, 62, 63]. These previous studies were
limited by the amount of data they incorporated, and their
conclusions therefore had constrained generalizability. Our
models, developed using large datasets from ten countries
with outcome data considered to be gold standard [64],
reached similar conclusions and so provide additional valid-
ation to this previous work.
The variation between countries in directions of asso-
ciation of environment-related indicators and the vari-
ation in spatial structure indicate that fitting a single
Table 6 Scale of community-level TT prevalence spatial
correlation in kilometres when accounting for covariates
significant at the 5% level, by country with 95% confidence
intervals
Country scale of spatial correlation 95% confidence intervals
Benin 3.2 km 0.8–12.8 km
DRC 7.7 km 3.0–20.1 km
Ethiopia 3.0 km 1.6–6.0 km
Mozambique 14.2 km 3.4–48.9 km
Sudan 2.8 km 0.9–10.8 km
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model to the whole set of data is inadvisable. These vari-
ations are presumably attributable to country context.
There may be several explanations for the inconsist-
ency of associations between large-scale indicators and
community-level TT seen between countries. Studies have
shown that post-operative recurrence of TT [55, 65, 66]
and incidence of scaring [67, 68] may be important influ-
encers of TT prevalence. It would be valuable for future
models to further explore these elements. Our modelling
approach did not capture recent or historical population
movement. Migration could certainly play a role in the
geographic distribution of TT. It is also important to note
that different ethnic groups may have different progres-
sion rates to TT. For example, a study in the Gambia
found a polymorphism in the TNF-α gene promoter was
associated with scarring, and was found more frequently
among Mandinkas than other ethnic groups [69].
We observed residual spatial correlation in only five
countries (Benin, DRC, Ethiopia, Mozambique, and
Sudan), suggesting that in the remaining countries there
are no outstanding large-scale environmental factors in-
fluencing progression to TT.
In the geostatistical models, we identified a very
rapid decline in spatial correlation with distance at
larger scales, after accounting for covariates. This sug-
gests that very closely adjacent communities have
similar levels of TT.
Conclusion
The lack of consistent risk factors beyond community-
level TF raises concerns that the models identified arte-
facts that are not generalizable, such as non-trachomatous
trichiasis, or that the clinical history of trachoma varies
substantially between settings. This underlines the import-
ance of understanding local context when designing inter-
ventions for at-risk populations. Whilst our findings are
not generalizable across countries, they can provide gen-
eral direction for where to initiate case finding activities.
As has been found in the Guinea Worm eradication pro-
gram, active surveillance and case finding will be essential
as trachoma elimination endpoints draw closer [70]; these
activities become more expensive as prevalence drops
[71]. This uniquely large and standardized analysis
provides important insight into the variation in
community-level TT distribution and identifies substantial
variation in the relationship between community-level TF
and TT prevalence. For some countries, important envir-
onmental risk factors were identified which can be used to
inform case finding efforts, by providing insight into
where TT cases are most likely to be found. Our findings
suggest that in some countries it is possible to inform stra-
tegic location of TT management services, potentially
improving efficiency of the end-game of trachoma
elimination.
Appendix 1
Table 7 GTMP Water, Sanitation, and Hygiene indicators.
Responses are classified as improved where marked with X
S1) Where do you and other adults in
the household usually defecate?
number of households reporting
that adults living in the household
defecate in either a shared public
latrine or a private latrine / number
of households enrolled in the survey
1) Shared or public latrine X
2) Private latrine X
3) No structure, outside
near the house
4) No structure, in the
bush or field
9) Other
S2) Improved latrine: What kind of toilet
facility do the adults in the household
use? Observed.
number of households where an
improved latrine is observed / number
of households enrolled in the survey
1) Flush/pour flush to
piped sewer system
X
2) Flush/pour flush to
septic tank
X
3) Flush/pour flush to pit
latrine
X
4) Flush/pour flush to
open drains
5) Flush/pour flush to
unknown place
X
6) Ventilated improved pit
latrine (VIP)
X
7) Pit latrine with slab X
8) Pit latrine without slab/
open pit
9) Composting toilet X
10) Bucket
11) Hanging toilet/hanging
latrine
12) No facilities or bush
or field
99) Other
H3) Improved Water source: In the
dry season, what is the main source
of water used by your household for
washing faces?
number of households reporting
to access improved water sources /
number of households
enrolled in the survey
1) Piped water into
dwelling
X
2) Piped water into
yard/pot
X
3) Public tap/standpipe X
4) Tubewell/borehole X
5) Protected dug well X
6) Unprotected dug well
7) Protected spring X
8) Unprotected spring
9) Rainwater collection X
10) Water vendor
11) Surface water (e.g. river,
dam, lake, canal)
99) Other
H4) Wash near: Washing water: If you
collected water there to bring back
to the house, how long does it take
to go there, get water,
and come back?
number of households reporting
access to improved water sources and those
water sources are on the premises /
number of households enrolled
in the survey
0) All face washing done
at the water source
1) Water source in the yard X
2) Less than 30 min
3) Between 30min and 1 h
4) More than 1 h
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Climate:
Fig. 3 5 km gridded climate raster maps. Data depicted in this map were obtained from the Consortium for Spatial Information (CGIAR-CSI) [41]. The
georeferenced raster files were converted to a 5 km× 5 km resolution and visualized by the manuscript authors using ArcGIS 10.1 (ESRI, Redlands, CA, USA)
Appendix 2
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Water access: Soil composition (fraction and soil properties):
Fig. 4 5 km gridded Euclidian distance to water raster map. The
manuscript authors produced a continuous surface of distances in
km to the nearest water body and permanent rivers based on data
obtained from the Global Database of Lakes, Reservoirs and
Wetlands [72]
Fig. 5 5 km gridded soil composition sand fraction raster map. Data
depicted in this map were obtained from the ISRIC-World Soil Infor-
mation project included in the Harmonized Soil Map of the World
[43]. The georeferenced raster files were converted to a 5 km × 5 km
resolution and visualized by the manuscript authors using ArcGIS
10.1 (ESRI, Redlands, CA, USA)
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